相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis
Giulia Marzocchi et al.
BLOOD (2011)
Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score
Joerg Hasford et al.
BLOOD (2011)
Is carcinogenesis a form of speciation?
Peter Duesberg et al.
CELL CYCLE (2011)
Tolerability-Adapted Imatinib 800 mg/d Versus 400 mg/d Versus 400 mg/d Plus Interferon-α in Newly Diagnosed Chronic Myeloid Leukemia
Ruediger Hehlmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Recommendations to meet statistical challenges arising from endpoints beyond overall survival in clinical trials on chronic myeloid leukemia
M. Pfirrmann et al.
LEUKEMIA (2011)
Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era: evaluation of its impact within a subgroup of the randomized German CML Study IV
Susanne Saussele et al.
BLOOD (2010)
Loss of the Y chromosome in Philadelphia-positive cells predicts a poor response of chronic myeloid leukemia patients to imatinib mesylate therapy
Eric Lippert et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Deletions of the Derivative Chromosome 9 Do Not Influence the Response and the Outcome of Chronic Myeloid Leukemia in Early Chronic Phase Treated With Imatinib Mesylate: GIMEMA CML Working Party Analysis
Fausto Castagnetti et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Similar patterns of chromosome abnormalities in CML occur in addition to the Philadelphia chromosome with or without tyrosine kinase inhibitor treatment
C. Haferlach et al.
LEUKEMIA (2010)
Chronic myeloid leukemia: a prospective comparison of interphase fluorescence in situ hybridization and chromosome banding analysis for the definition of complete cytogenetic response: a study of the GIMEMA CML WP
Nicoletta Testoni et al.
BLOOD (2009)
Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet
Michele Baccarani et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Harmonization of molecular monitoring of CML therapy in Europe
M. C. Mueller et al.
LEUKEMIA (2009)
Specific clones of spontaneously evolving karyotypes generate individuality of cancers
Alice Fabarius et al.
CANCER GENETICS AND CYTOGENETICS (2008)
BCR/ABL, DNA damage and DNA repair: Implications for new treatment concepts
Tomasz Skorski
LEUKEMIA & LYMPHOMA (2008)
Harmonization of BCR-ABL mRNA quantification using a uniform multifunctional control plasmid in 37 international laboratories
M. C. Mueller et al.
LEUKEMIA (2008)
Heterogeneous prognostic impact of derivative chromosome 9 deletions in chronic myelogenous leukemia
Sebastian Kreil et al.
BLOOD (2007)
Chronic myeloid leukaemia
Ruediger Hehlmann et al.
LANCET (2007)
Chronic myeloid leukaemia as a model of disease evolution in human cancer
Junia V. Melo et al.
NATURE REVIEWS CANCER (2007)
Staging of chronic myeloid leukemia in the imatinib era - An evaluation of the World Health Organization proposal
JE Cortes et al.
CANCER (2006)
Results of imatinib mesylate therapy in chronic myelogenous leukaemia with variant Philadelphia chromosome
MMT El-Zimaity et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Clonal evolution and lack of cytogenetic response are adverse prognostic factors for hematologic relapse of chronic phase CML patients treated with imatinib mesylate
ME O'Dwyer et al.
BLOOD (2004)
MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors
BJP Huntly et al.
CANCER CELL (2004)
A potential role for PRDM12 in the pathogenesis of chronic myeloid leukaemia with derivative chromosome 9 deletion
AG Reid et al.
LEUKEMIA (2004)
Imatinib improves but may not fully reverse the poor prognosis of patients with CML with derivative chromosome 9 deletions
BJP Huntly et al.
BLOOD (2003)
Prognostic significance of cytogenetic clonal evolution in patients with chronic myelogenous leukemia on imatinib mesylate therapy
JE Cortes et al.
BLOOD (2003)
Genomic deletions on other chromosomes involved in variant t(9;22) chronic myeloid leukemia cases
F Albano et al.
GENES CHROMOSOMES & CANCER (2003)
Occurrence of additional chromosome aberrations in chronic myeloid leukemia patients treated with imatinib mesylate
C Schoch et al.
LEUKEMIA (2003)
The impact of clonal evolution on response to imatinib mesylate (ST1571) in accelerated phase CML
ME O'Dwyer et al.
BLOOD (2002)
Specific aneusomies in Chinese hamster cells at different stages of neoplastic transformation, initiated by nitrosomethylurea
A Fabarius et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases
C Schoch et al.
LEUKEMIA (2002)
分享论文
